Hodgkin’s Disease

  • J. R. Durant
Part of the UICC Current Treatment of Cancer book series (1360)


The purpose of this essay concerning Hodgkin’s disease is to provide a general overview of the disease, to describe the general approach taken at the Fox Chase Cancer Center, and to speculate on future directions which might be taken to improve results. An attempt to present principles is made. Further, it is recognized that the management is complex and often involves sophisticated clinical techniques and equipment, particularly in radiotherapy. In general, if sophisticated staging techniques are not available, surgical approaches will be necessary, and if sophisticated radiotherapy cannot be done, the chemotherapeutic regimens described can be substituted.


Complete Remission Extended Field Radiotherapy Milan Group Eastern Cooperative Oncology Group Study Total Nodal Irradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. Bakemeier RF, Anderson JR, Castello W et al. (1984) BCVPP chemotherapy for advanced Hodgkin’s disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Ann Intern Med 101: 447–456PubMedGoogle Scholar
  2. Carbone PP, Kaplan HS, Masshoff K et al. (1971) Report of the committee on Hodgkin’s disease staging. Cancer Res 31: 1860–1861PubMedGoogle Scholar
  3. DeVita VT Jr (1982) Principles of chemotherapy. In: DeVita VT Jr, Heilman S, Rosenberg SA (eds) Cancer principles and practice of oncology. Lippincott, Philadelphia, pp 132–155Google Scholar
  4. DeVita VT, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73: 891–895Google Scholar
  5. Durant JR, Gams RA, Velz-Garcia E et al. (1978) BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin’s disease. Cancer 42: 2101–2110PubMedCrossRefGoogle Scholar
  6. Lukes RJ, Butler JJ, Hicks ED (1966) Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer 19: 317–344CrossRefGoogle Scholar
  7. Rosenberg SA (1985) Hodgkin’s disease. In: Galabresi P, Schein PS, Rosenberg SA (eds) Medical oncology, basic principles and clinical management of cancer. Macmillan, New York, pp. 457–475Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • J. R. Durant

There are no affiliations available

Personalised recommendations